|
Lupus Federal Working Group
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, HRSA, OS
|
NIAMS, NCCIH, NEI, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIEHS, NIMHD, NINDS, OD/DPCPSI/OBSSR, OD/DPCPSI/ORWH
|
The Lupus Federal Working Group, established on behalf of the HHS Secretary by the NIH, facilitates collaboration among NIH components, other Federal agencies, voluntary and professional organizations, and industry groups with an interest in lupus.
|
|
Lyme and Tick-borne Diseases Work Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NIAID
|
This work group involves members from agencies including the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and the NIH with the purpose of continued coordination and communication of activities, policy updates, events, agency highlights, and other shared interests relating to Lyme disease and other tick-borne diseases.
|
|
Mapping of the Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT) and International Classification of Disease (ICD) Clinical Terminology
|
Resource Development
|
CDC, OS
|
NLM
|
The U.S. Department of Health and Human Services (HHS) has set a goal for the nationwide implementation of an interoperable health information technology infrastructure to improve the quality and efficiency of health care. Achieving this goal will require that key clinical data elements are captured or recorded in detailed, standardized form (using standard vocabularies, codes, and formats) as close to their original sources (patients, health care providers, laboratories, diagnostic devices, etc.) as possible. If these standardized clinical data can also be used to generate HIPAA- compliant billing transactions automatically, this will provide another incentive for adoption of clinical data standards. For automated generation of bills from clinical data to become a reality, robust mappings from standard clinical terminologies to the HIPAA code sets must be created. To support the transition to ICD-10-CM in 2015, a map from SNOMED CT to ICD-10-CM is being created.
|
|
Medical Countermeasures Surveillance Integrated Program Team
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NIAID
|
This team was created to identify the regulatory science research required for real‐time tracking and evaluation of medical countermeasures (MCMs) during public health emergencies. The team is developing a comprehensive Action Plan to identify and facilitate the development of systems that can be used to monitor MCM safety and clinical benefit during an event.
|
|
Medical Device Research Interest Group
|
Other
|
FDA
|
NICHD
|
The purpose of the group is to increase collaboration and communication regarding specific initiatives or policies that affect medical device development, regulatory approval, and commercialization.
|
|
Medical Education Partnership Initiative (MEPI)
|
Training Initiative
|
CDC, HRSA
|
FIC, NCI, NHGRI, NHLBI, NIMH, NINDS, NINR, OD/DPCPSI/OAR, OD/DPCPSI/ORWH, OD/DPCPSI/OSC
|
The Medical Education Partnership Initiative (MEPI) builds human capacity for health in Africa by strengthening the medical education system in an environment that values and nurtures research in President’s Emergency Plan for AIDS Relief (PEPFAR)-funded countries. MEPI aims to advance PEPFAR''s goal of increasing the number of new health care workers by 140,000; strengthen in-country medical education systems; and build clinical and research capacity in Africa as part of a retention strategy for faculty of medical schools and clinical professors. The 13 awards administered by FIC/NIH are either in a no-cost extension to complete their activities or they have completed.
MEPI recently began a stage 2 and NIH is working with PEPFAR on two new program concepts that build on the success of the first stage. The first would support a governing body to continue networking activities among health educators in Africa and the second would fund efforts to strengthen training and retention of health care professionals; encourage research to improve and evaluate educational practices; and enhance capacity to develop, implement and evaluate evidence-based services with an emphasis on HIV/AIDS.
NIH/MEPI works in collaboration with OGAC and HRSA.
|
|
Medical Expenditure Panel Survey (MEPS)
|
Health Survey
|
AHRQ
|
NCI
|
The Medical Expenditure Panel Survey (MEPS) is a set of large-scale surveys of families and individuals, their medical providers, and employers across the United States. MEPS is the most complete source of data on the cost and use of health care and health insurance coverage.
|
|
Memorandum of Understanding (MOU) between the FDA Center for Devices and Radiological Health and NIH/NINDS
|
Other
|
FDA
|
NINDS
|
This MOU provides a mechanism for addressing cross-cutting issues related to the development of devices for neurological disorders, from bench science to clinical studies and FDA approval.
|
|
Memorandum of Understanding (MOU) between the FDA/Center for Biologics Evaluation and Research (FDA/CBER) and NIH/NINDS
|
Other
|
FDA
|
NINDS
|
This Memorandum of Understanding (MOU) provides a mechanism for addressing cross-cutting issues related to therapy development for neurological disorders, from bench science to clinical trials and FDA approval and licensure.
|
|
Memorandum of Understanding Between National Toxicology Program (NTP) and NIH/NIEHS, FDA, and CDC/NIOSH
|
Other
|
CDC, FDA
|
NIEHS
|
The interagency NTP, established in 1978 and administratively headquartered at NIH/NIEHS, is an ongoing cooperative effort to evaluate substances of public health concern, develop improved methods, strengthen the science base in toxicology, and provide information important for decisions to safeguard public health. This MOU between FDA, NIH/NIEHS, CDC/NIOSH and NTP affirms a commitment to provide resources dedicated toward carrying out NTP’s mission and outlines various administrative and managerial actions the agencies will take to support NTP’s activities.
|